Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

A LoGiCal® Solution for Forensic Toxicology

Published: Monday, November 19, 2012
Last Updated: Sunday, November 18, 2012
Bookmark and Share
LoGiCal reference solutions are good quality and always ready for use.

LGC Standards’ LoGiCal® reference materials are proving a valuable resource for scientists at the Institute of Forensic Research in Krakow, Poland.

Dr Dariusz Zuba, head of the Alcohol and Drug Analysis Laboratory in the Department of Forensic Toxicology, explained: “The Institute is part of the Ministry of Justice and undertakes casework for the courts, as well as carrying out research studies. When we need to purchase reference materials we always contact LGC Standards. The Company’s Polish office is very good at keeping us informed about recent developments and new products.”

“Our standard analytical protocols involve the analysis of samples by both GC-MS and HPLC. In more complex cases, we use LC-QTOFMS. We identify any new materials - legal highs - seized from the market and, if a drug is on the list of controlled substances, we perform quantitative analysis. LoGiCal reference solutions are ideal for this purpose because no preparation is needed, and we have used them to screen for drugs of abuse such as amphetamines and cocaine, as well as for research studies. The solutions are good quality and, unlike powders, are always ready for use; we just dilute them to the appropriate concentration. The uncertainty is also given, which is extremely important. It just makes no sense to buy standards without a Certificate of Analysis.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Reference Materials Sourced to Meet the Needs of the World's Leading Toxicologists
Testing for ‘designer drugs’, ‘legal highs’ and other novel materials is a continuing challenge for clinical, forensic, sports testing and toxicology laboratories.
Tuesday, October 07, 2008
Scientific News
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Self-Propelled Powder to Stop Bleeding
UBC researchers have created the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care.
Tension Helps Heart Cells Develop Normally in the Lab
Stanford engineers have uncovered the important role tension plays in growing heart cells out of the body.
Controlling Body Temperature in Response to 'Fight or Flight'
New research in The FASEB Journal suggests that blocking TRPV1 protein causes an increased release of noradrenaline, leading to an increase in core body temperatures.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
A Fundamental Protection Mechanism Against Formalin In Mammals is Revealed
Formaldehyde, or formalin, is well known to all of us as a common chemical used in many industrial processes and also as a preservative, remarkably we also produce formaldehyde in our bodies.
Drug Used To Treat HIV Linked to Lower Bone Mass in Newborns
NIH study finds mothers’ use of tenofovir tied to lower bone mineral content in babies.
Bone Risks Linked to Genetic Variants
A large-scale genomic study uncovered novel genetic variants and led researchers to an unexpected gene that affects bone density and fracture risk.
Combo of 3 Antibiotics Can Kill Deadly Staph Infections
Three antibiotics that, individually, are not effective against a drug-resistant staph infection can kill the deadly pathogen when combined as a trio, according to new research.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos